Sugita R, Deguchi K, Fujimaki Y, Asai S, Okano K, Komatsu N, Shimizu K, Saito S, Watanabe H, Naito M
Sugita Otorhinolaryngologic Clinic.
Jpn J Antibiot. 1994 Sep;47(9):1219-30.
We carried out clinical and bacteriological studies on sultamicillin (SBTPC) in pediatric sinusitis at 10 general practice settings. The results are summarized as follows. 1. The major isolated organisms from purulent nasal discharges were Streptococcus pneumoniae 27.5%, Haemophilus influenzae 32.4% and Moraxella catarrhalis 9.9%. Similar results were observed for the major isolates from nasopharynx. 2. 33% of the isolated S. pneumoniae were penicillin-insensitive S. pneumoniae (PISP) against which the MICs were equal to or higher than 0.1 microgram/ml. 3. PISP was isolated from 14% of all cases. 4. The clinical efficacy rate was 77.5% and was deemed satisfactory. 5. In the bacteriological study, persistence rate of PISP was 38.5% among the PISP from purulent nasal discharge and 60.0% among the PISP from nasopharynx which and these values were significantly higher than persistence rates of PSSP, H. influenzae and M. catarrhalis. 6. Adverse reactions were observed in 21.5% of all cases, involving diarrhea and loose stool.
我们在10个全科诊所对小儿鼻窦炎患者开展了关于舒他西林(SBTPC)的临床和细菌学研究。结果总结如下:1. 脓性鼻分泌物中分离出的主要病原体为肺炎链球菌(27.5%)、流感嗜血杆菌(32.4%)和卡他莫拉菌(9.9%)。鼻咽部分离出的主要病原体也得到了类似结果。2. 分离出的肺炎链球菌中有33%是青霉素不敏感肺炎链球菌(PISP),其最低抑菌浓度等于或高于0.1微克/毫升。3. 所有病例中有14%分离出了PISP。4. 临床有效率为77.5%,被认为令人满意。5. 在细菌学研究中,脓性鼻分泌物来源的PISP持续存在率为38.5%,鼻咽部分离出的PISP持续存在率为60.0%,这些数值显著高于青霉素敏感肺炎链球菌、流感嗜血杆菌和卡他莫拉菌的持续存在率。6. 所有病例中有21.5%出现了不良反应,包括腹泻和稀便。